Welcome to LookChem.com Sign In|Join Free
  • or
5,6-Dimethoxy-benzo[b]thiophene-2-carboxylic acid methyl ester is a heterocyclic compound with the chemical formula C13H12O4S. It is a methyl ester derivative of benzo[b]thiophene-2-carboxylic acid and belongs to the family of benzene and substituted derivatives. This chemical is primarily used in pharmaceutical research and drug development due to its potential biological activities.

35212-99-8

Post Buying Request

35212-99-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

35212-99-8 Usage

Uses

Used in Pharmaceutical Research and Drug Development:
5,6-Dimethoxy-benzo[b]thiophene-2-carboxylic acid methyl ester is used as a compound with potential pharmaceutical applications for its anti-inflammatory and antimicrobial properties. It is being studied for its potential applications in the treatment of various diseases and disorders.
Used in Anti-inflammatory Applications:
5,6-Dimethoxy-benzo[b]thiophene-2-carboxylic acid methyl ester is used as an anti-inflammatory agent, which can help in reducing inflammation and pain associated with various conditions.
Used in Antimicrobial Applications:
5,6-Dimethoxy-benzo[b]thiophene-2-carboxylic acid methyl ester is used as an antimicrobial agent, which can help in treating infections caused by bacteria and other microorganisms.

Check Digit Verification of cas no

The CAS Registry Mumber 35212-99-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,2,1 and 2 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 35212-99:
(7*3)+(6*5)+(5*2)+(4*1)+(3*2)+(2*9)+(1*9)=98
98 % 10 = 8
So 35212-99-8 is a valid CAS Registry Number.
InChI:InChI=1/C12H12O4S/c1-14-8-4-7-5-11(12(13)16-3)17-10(7)6-9(8)15-2/h4-6H,1-3H3

35212-99-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 5,6-dimethoxy-1-benzothiophene-2-carboxylate

1.2 Other means of identification

Product number -
Other names methyl 5,6-dimethoxybenzothiophen-2-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:35212-99-8 SDS

35212-99-8Relevant academic research and scientific papers

BENZOTHIOPHENE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF

-

Paragraph 0183; 0184; 0185, (2022/03/22)

A compound represented by formula (I) or a pharmaceutically acceptable salt, a stereoisomer, a tautomer, a polymorph, a solvate, an N-oxide, an isotope labeled compound, a metabolite or a prodrug thereof, a pharmaceutical composition and a pill container comprising same, a preparation method therefor, and the use thereof in the preparation of drugs for preventing or treating STING-mediated related diseases.

DIMERIC COMPOUNDS AS STING AGONISTS

-

Paragraph 537, (2021/06/11)

The present disclosure relates to dimeric STING agonists of Formulae (I), (II), (III), (IV), (V), and (VI), and pharmaceutically acceptable salts thereof. The present disclosure also relates to methods of preparing the compounds and methods of using the c

Amide compound and preparation method and application thereof

-

Paragraph 0200-0204, (2020/11/12)

The invention relates to an amide compound and a preparation method and application thereof. Specifically, the present invention relates to a compound of formula I or a pharmaceutically acceptable salt, stereoisomer, tautomer, polymorph, solvate, N-oxide, isotope labeled compound, metabolite or prodrug thereof, pharmaceutical compositions and kits comprising the same, processes for their preparation and their use in the preparation of medicaments for the treatment of STING-mediated related diseases.

Benzothiophene amide compound and preparation method and application thereof

-

Paragraph 0204-0207, (2020/11/12)

The invention relates to a benzothiophene amide compound and a preparation method and application thereof. Specifically, the present application relates to a compound represented by formula (I), a stereoisomer, a tautomer, a polymorph, an N-oxide, an isotope labeled compound, a metabolite or a prodrug thereof, or a solvate or a pharmaceutically acceptable salt thereof, and the compound can be usedfor preparing a drug for treating a cell proliferative disease.

BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS

-

Paragraph 0461; 0462, (2018/04/18)

Compounds of general formula (Ia), compounds of general formula (Ia′), compounds of general formula (Ib), compounds of general formula (Ib′), compounds of general formula (I), compounds of general formula (I′), and their pharmaceutically acceptable salts,

THE 5,6-DIMETHOXY-1, 1-DIOXOBENZO(B)THIOPHENE-2-METHYLOXYCARBONYL (DM-BSMOC) AND RELATED AMINO-PROTECTING GROUPS

-

, (2015/02/02)

Amino acid protecting groups are provided for use in peptide synthesis. Particular compounds disclosed include 5,6-dimethoxy-l,l-dioxobenzo[b]thiophi methyloxycarbonyl (DM-Bsmoc) and related amino-protecting groups.

Efficient synthetic approach to substituted benzo[b]furans and benzo[b]thiophenes by iodine-promoted cyclization of enaminones

Labarrios, Ehecatl,Jerezano, Alberto,Jimenez, Fabiola,Del Carmen Cruz, Maria,Delgado, Francisco,Zepeda, L. Gerardo,Tamariz, Joaquin

, p. 954 - 971 (2014/08/05)

An efficient synthetic approach to the substituted benzo[b]furan and benzo[b]thiophene scaffolds by iodine-mediated cyclization of the corresponding enaminones is described. This protocol was applied to a large series of these latter precursors to afford the respective benzoheterocycles substituted at the C-2 position by a carbonyl group functionality. A study of the factors that control this process reveals that the reactivity depends on the presence of electron-donor groups in the aryl ring of the aryloxycarbonylic and arylthiocarbonylic moieties.

FUSED RING ANALOGUES OF ANTI-FIBROTIC AGENTS

-

Page/Page column 97, (2011/05/06)

The present invention relates to arylcarbonyl and heteroarylcarbonyl anthranilate compounds that may be useful as anti-fibrotic agents. The present invention also relates to methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment disorders.

Benzothiophene derivatives and medicinal use thereof

-

, (2008/06/13)

A benzothiophene derivative represented by formula (1): can activate a peroxisome proliferator-activated receptor (PPAR) α or γ which is an intranuclear transcription factor. The compound may be used as an active ingredient to give a drug for preventing o

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 35212-99-8